| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.2M | -4.6% |
| R&D Expense | $43.3M | +24.1% |
| SG&A Expense | $19.6M | +13.6% |
| Operating Income | -$53.0M | -26.0% |
| Net Income | -$56.7M | -24.7% |
| EPS (Basic) | $0.61 | +222.0% |
| EPS (Diluted) | $0.61 | +222.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.7M | -50.9% |
| Short-term Investments | $66.0M | -13.1% |
| Accounts Receivable | $3.0M | -7.7% |
| Current Assets | $92.1M | -24.7% |
| Total Assets | $108.8M | -32.9% |
| Current Liabilities | $10.0M | -25.5% |
| Long-term Debt | $900K | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$54.3M | -44.4% |
| Capital Expenditures | $416K | — |
| Investing Cash Flow | $33.0M | +168.9% |
| Financing Cash Flow | $867K | +120.8% |
| Free Cash Flow | -$54.8M | -45.5% |
| Total Liabilities |
| $62.3M |
| -13.0% |
| Stockholders' Equity | $46.6M | -48.7% |